CytoAgents Employee Directory

CytoAgents corporate office is located in 100 S Commons Ste 102, Pittsburgh, Pennsylvania, 15212, United States and has 11-50 employees.

Key Employees of CytoAgents

  • MF
    United States flag for contact location.
    Matthew Frigau...

    Cellular Immunotherapy Program Clinical Director

    PhonePhoneEmailEmail
  • BC
    United States flag for contact location.
    Boyle Cheng

    Director of the Neuroscience Institute, AHN

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

CytoAgents Global Presence

globalPresence illustration
North America1-10

Index of contact profiles from CytoAgents

Hundreds of professionals searching for CytoAgents have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

Former Employees at CytoAgents

Explore people who held key positions, contributed to CytoAgents's success, and advanced their careers.

People from Similar Companies in the Manufacturing Industry Located in Pennsylvania, United States

Frequently Asked Questions Regarding CytoAgents Employees

How many employees does CytoAgents have?
CytoAgents has 11-50 employees
Who are CytoAgents key employees?
Some of CytoAgents key employees are Matthew Frigault, Boyle Cheng
Where is CytoAgents located?
CytoAgents’s headquarters are located at 100 S Commons Ste 102, Pittsburgh, Pennsylvania, 15212, United States
How do I contact CytoAgents?
CytoAgents Contact Info: Phone number: (412) 303-1200 Website: www.cytoagents.com
What does CytoAgents do?

CytoAgents is focused on developing innovative pharmaceutical products aimed at treating symptoms associated with Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS). Their lead product, CTO1681, is an orally bioavailable, steroid-sparing immunomodulator designed to address inflammation driven by cytok... ine activity in various diseases, including oncology and inflammatory conditions. The company is currently conducting clinical trials to evaluate the efficacy of CTO1681 in patients undergoing CAR T-Cell therapy, where inflammation poses significant treatment challenges. CytoAgents aims to enhance patient outcomes by providing safer and more effective treatment options for those affected by inflammatory diseases.Read More

Is CytoAgents a public company?
CytoAgents is private company therefore does not currently have an official ticker symbol
See more information about CytoAgents Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.